Treatment registry for outcomes in patients with castration-resistant prostate cancer (TRUMPET): a methodology for real-world evidence and research

被引:5
作者
Penson, David F. [1 ]
Lin, Daniel W. [2 ]
Karsh, Lawrence [3 ]
Quinn, David I. [4 ]
Shevrin, Daniel H. [5 ]
Shore, Neal [6 ]
Symanowski, James T. [7 ]
Brown, Bruce [8 ]
Forer, David [9 ]
Wong, Elaine K. [9 ]
Flanders, Scott C. [8 ]
机构
[1] Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA
[2] Univ Washington, Seattle, WA 98195 USA
[3] Urol Ctr Colorado, Denver, CO USA
[4] USC Norris Comprehens Canc Ctr, Los Angeles, CA USA
[5] North Shore Univ Hlth Syst, Evanston, IL USA
[6] Carolina Urol Res Ctr, Myrtle Beach, SC USA
[7] Carolinas HealthCare Syst, Levine Canc Inst, Charlotte, NC USA
[8] Astellas Pharma Inc, Northbrook, IL USA
[9] Medivation Inc, San Francisco, CA USA
关键词
castration-resistant prostate cancer; health-related quality of life; treatment utilization; QUALITY-OF-LIFE; VALIDATION; THERAPY; INSTRUMENT; HEALTH; SCALE; MEN;
D O I
10.2217/fon-2016-0298
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: This study seeks to improve the understanding of treatment patterns and associated health-related quality of life (HRQoL), clinical outcomes and healthcare utilization in US patients with castration-resistant prostate cancer (CRPC). Patients & methods: Treatment Registry for Outcomes in CRPC Patients (TRUMPET) is a US-based, prospective, observational multicenter registry (NCT02380274) involving patients with CRPC and their caregivers. Patients initiating their first active treatment course will be enrolled from urology and medical oncology practices, with data captured up to 4 years. Results: Information on prescribing patterns, HRQoL, clinical outcomes and healthcare utilization will be collected. Conclusion: TRUMPET will enable scientific understanding of disease management in terms of HRQoL, clinical outcomes and healthcare utilization in clinical practice for patients with CRPC.
引用
收藏
页码:2689 / 2699
页数:11
相关论文
共 25 条
[11]   Prostate Cancer Registries: Current Status and Future Directions [J].
Gandaglia, Giorgio ;
Bray, Freddie ;
Cooperberg, Matthew R. ;
Karnes, R. Jeffrey ;
Leveridge, Michael J. ;
Moretti, Kim ;
Murphy, Declan G. ;
Penson, David F. ;
Miller, David C. .
EUROPEAN UROLOGY, 2016, 69 (06) :998-1012
[12]  
Gliklich RE, Registries for evaluating patient outcomes. A user's guide, V4th
[13]   The CaPSURE database: A methodology for clinical practice and research in prostate cancer [J].
Lubeck, DP ;
Litwin, MS ;
Henning, JM ;
Stier, DM ;
Mazonson, P ;
Fisk, R ;
Carroll, PR .
UROLOGY, 1996, 48 (05) :773-777
[14]   Activation of the Androgen Receptor by Intratumoral Bioconversion of Androstanediol to Dihydrotestosterone in Prostate Cancer [J].
Mohler, James L. ;
Titus, Mark A. ;
Bai, Suxia ;
Kennerley, Brian J. ;
Lih, Fred B. ;
Tomer, Kenneth B. ;
Wilson, Elizabeth M. .
CANCER RESEARCH, 2011, 71 (04) :1486-1496
[15]   Living with prostate cancer: Patients' and spouses' psychosocial status and quality of life [J].
Northouse, Laurel L. ;
Mood, Darlene W. ;
Montie, James E. ;
Sandler, Howard M. ;
Forman, Jeffrey D. ;
Hussain, Maha ;
Pienta, Kenneth J. ;
Smith, David C. ;
Sanda, Martin G. ;
Kershaw, Trace .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (27) :4171-4177
[16]   Patient experience in the treatment of metastatic castration-resistant prostate cancer: state of the science [J].
Nussbaum, N. ;
George, D. J. ;
Abernethy, A. P. ;
Dolan, C. M. ;
Oestreicher, N. ;
Flanders, S. ;
Dorff, T. B. .
PROSTATE CANCER AND PROSTATIC DISEASES, 2016, 19 (02) :111-121
[17]   The example of CaPSURE: lessons learned from a national disease registry [J].
Porten, Sima P. ;
Cooperberg, Matthew R. ;
Konety, Badrinath R. ;
Carroll, Peter R. .
WORLD JOURNAL OF UROLOGY, 2011, 29 (03) :265-271
[18]   THE VALIDITY AND REPRODUCIBILITY OF A WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT INSTRUMENT [J].
REILLY, MC ;
ZBROZEK, AS ;
DUKES, EM .
PHARMACOECONOMICS, 1993, 4 (05) :353-365
[19]   Spousal responses to prostate cancer: An integrative review [J].
Resendes, LA ;
McCorkle, R .
CANCER INVESTIGATION, 2006, 24 (02) :192-198
[20]   The memorial anxiety scale for prostate cancer - Validation of a new scale to measure anxiety in men with prostate cancer [J].
Roth, AJ ;
Rosenfeld, B ;
Kornblith, AB ;
Gibson, C ;
Scher, HI ;
Curley-Smart, T ;
Holland, JC ;
Breitbart, W .
CANCER, 2003, 97 (11) :2910-2918